Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. Post author:Sam Post published:October 24, 2017 Post category:BioPharma Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace You Might Also Like FDA Issues New Draft Guidance for Alzheimer’s Trials that Could Open Up Approvals March 1, 2018 Bay Area's IMPAX Labs Surges on Merger Buzz September 21, 2017 Bristol-Myers, Johnson & Johnson Get in on Europeon Biotech Fund's $95M Raise October 30, 2017
